Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
about
Diagnosis and treatment of high density lipoprotein deficiencyAssociation of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.Cholesteryl ester transfer protein gene polymorphisms and longevity syndromeCommon genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.Association of cholesteryl ester transfer protein genotypes with paraoxonase-1 activity, lipid profile and oxidative stress in type 2 diabetes mellitus: A study in San Luis, ArgentinaNatural genetic variation as a tool in understanding the role of CETP in lipid levels and disease.Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy.Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians.Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations.Cholesteryl ester transfer protein TaqIB polymorphism and its association with serum lipid levels and longevity in Chinese Bama Zhuang population.Novel HDL-directed pharmacotherapeutic strategies.Association between TaqIB polymorphism of cholesteryl ester transfer protein and coronary artery disease in the Chinese population.Meta-analysis of cholesteryl ester transfer protein TaqIB polymorphism and risk of myocardial infarction.Inhibitors of cholesteryl ester transfer protein--a new approach to coronary artery disease.Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.The impact of common polymorphisms in CETP and ABCA1 genes with the risk of coronary artery disease in Saudi Arabians.Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of AtherosclerosisCholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke.Association of I405V polymorphism of colesteryl ester transfer protein gene with coronary artery disease in men with type 2 diabetesViability of developing CETP inhibitors.Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.Cholesterol ester transfer protein (CETP) gene polymorphism and selected parameters of lipid metabolism in children from families with history of cardiovascular system diseases.Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.CETP TaqIB Polymorphism, Serum Lipid Levels And Risk Of Atrial Fibrillation: A Case-Control Study.HMG-CoA reductase inhibitor pharmacogenomics: overview and implications for practice.Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors.CETP Inhibition: does the future look promising?HDL and CETP Inhibition: Will This DEFINE the Future?Biochemical characterization of cholesteryl ester transfer protein inhibitorsIs good cholesterol always good?High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: the Rancho Bernardo Study.Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity.Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.Effect of the cholesteryl ester transfer protein genotypes on plasma lipid and lipoprotein levels in Vietnamese children.Overexpression of Cholesteryl Ester Transfer Protein Increases Macrophage-Derived Foam Cell Accumulation in Atherosclerotic Lesions of Transgenic Rabbits.Genetic Risk Factors in Cerebrovascular Disorders and Cognitive Deterioration.Taq1B Polymorphism of Cholesteryl Ester Transfer Protein (CETP) and Its Effects on the Serum Lipid Levels in Metabolic Syndrome Patients.Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia.
P2860
Q28067479-A6E588BD-C865-41E8-B7F0-962F6C2750E8Q33639433-D21BB065-7A87-4D46-9DC9-D5773B0280E1Q33699478-2D3D8083-F917-4D2A-B3B7-92B61B4578FCQ34287868-94FBF925-1D33-4AD1-92BF-3AD31959A797Q34976695-7C6AC344-8C6D-4B70-ACF9-C036CA0FB4B7Q35086131-326DDF38-3F8A-41E4-8B7A-23A81E8D71BCQ35127790-BB5A2A69-51CC-469A-8B2A-A7408C1A60E3Q35263448-7ABC2D4F-3500-4A45-B08A-F47E27BF30E9Q35732509-11C6BC69-9D38-43B0-A570-901DB2C37854Q35819287-BE1E583A-A9E5-4A4E-93EE-C931952E68C9Q35860020-93538EBA-480A-48CD-98A6-7D96A997BA42Q35946388-99333EF3-5806-4C42-BA94-E4A1666A5A73Q36193798-2A68C8DC-97D7-4E50-AEE5-7257D16051DCQ36376429-AC0D832E-277E-40F9-A5D7-F272DCDE560DQ36419283-7D21F99E-FF38-4FD4-8B33-BFC4422E1851Q36646137-095E36C5-37CA-422C-B913-E41A9CBF0BCEQ36730810-753C0041-8788-4EDF-B113-8E71C2BB07B3Q36961285-41AA5FBE-6A4B-4D5F-8A91-2EBF9EE9A24DQ37067178-C031DDB4-DC33-4165-89CE-FA46679880F5Q37165682-8DE22FA1-E5EE-4BFF-8F55-409017F5D855Q37179542-E99C8C6E-C9E0-42FB-91D4-77702CE3D1E3Q37225638-467E48D8-B8A9-4E19-9CC7-CAC4C3A7B5BDQ37456662-2D906974-452E-43FE-80DC-9E627CE589B6Q37469031-C8F84BC7-30AD-49AC-9B7E-C869D2A0F6B4Q37608527-35CF18A5-AA54-4515-AF64-37554B1EF108Q37768794-03AC49D0-66D7-422D-BDE1-A976EA34B2F0Q37930463-D4CCCB7F-DAC6-4B3E-9E6D-EA44F1CE0393Q39598288-CC7F6CDE-73DF-4490-9AA3-66265B06DD9BQ42107210-E982B418-BC7C-42FF-9DB7-7AF1DE0ED175Q42390165-2B4DBBF8-FB90-4409-AD92-0FF11C1893AEQ43082140-7F018351-E411-4DB2-8431-88871FED55CFQ44325087-188B05EE-32A0-4566-AFEE-6C85F547A144Q46622451-3F16FFAB-F569-442B-9FA3-49FE7DD7091EQ46818505-4B32750F-3E51-4667-98CD-A3A991CE8B0FQ47215470-127A7730-78FC-4896-B93D-561C1559E5FEQ47590149-142C4E55-B1FD-475D-B43C-747FCC03D908Q51591547-6B7A8B7B-08F0-4BC8-8AAD-51CAFC403BB3Q51738459-55929EBC-05FD-4BAB-8210-A95366EA1C11
P2860
Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Cholesteryl ester transfer pro ...... holesterol Intervention Trial.
@en
Cholesteryl ester transfer pro ...... holesterol Intervention Trial.
@nl
type
label
Cholesteryl ester transfer pro ...... holesterol Intervention Trial.
@en
Cholesteryl ester transfer pro ...... holesterol Intervention Trial.
@nl
prefLabel
Cholesteryl ester transfer pro ...... holesterol Intervention Trial.
@en
Cholesteryl ester transfer pro ...... holesterol Intervention Trial.
@nl
P2093
P50
P1476
Cholesteryl ester transfer pro ...... holesterol Intervention Trial.
@en
P2093
Dorothea Collins
Ernst J Schaefer
James D Otvos
John J O'Connor
Judith R McNamara
Margaret E Brousseau
Tatyana Massov
P304
P356
10.1161/01.ATV.0000024566.57589.2E
P407
P577
2002-07-01T00:00:00Z